» Articles » PMID: 33125856

Prevalence, Risk Factors and Disease Knowledge of Polycystic Kidney Disease in Pakistan

Overview
Publisher Sage Publications
Date 2020 Oct 30
PMID 33125856
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Polycystic kidneys disease refers to cyst(s) formation in kidneys with severe consequences of end stage renal disease thus have higher mortality. It is a common genetic disease occurring either as autosomal dominant polycystic kidney (ADPKD) or autosomal recessive polycystic kidney disease (ARPKD) with prevalence rates of 1/1000 and 1/40,000 respectively. Dominant forms presenting in later (>30) while recessive in earlier ages (infancy) and affecting both sexes and almost all race. The patient experiences many renal as well as extra-renal manifestations with marked hypertension and cyst formation in other organs predominantly in liver. Due to genetic basis, positive family history is considered as major risk factor. Ultrasonography remains the main stay of diagnosis along with family history, by indicating increased renal size and architectural modifications. Initially disease remains asymptomatic, later on symptomatic treatment is suggested with surgical interventions like cyst decortications or drainage. Dialysis proved to be beneficial in end stage renal disease. However renal transplantation is the treatment of choice.

Citing Articles

Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease.

Kebede M, Mengistu Y, Loge B, Eshetu M, Shash E, Wirtu A J Pers Med. 2024; 14(9).

PMID: 39338190 PMC: 11433103. DOI: 10.3390/jpm14090936.


Autosomal dominant polycystic kidney disease (ADPKD) with multiple complications: Management challenges.

Djajapranata K, Tjempakasari A Narra J. 2024; 4(1):e584.

PMID: 38798842 PMC: 11125292. DOI: 10.52225/narra.v4i1.584.


Single-Center Experience of Pediatric Cystic Kidney Disease and Literature Review.

Grlic S, Gregurovic V, Martinic M, Davidovic M, Kos I, Galic S Children (Basel). 2024; 11(4).

PMID: 38671609 PMC: 11048964. DOI: 10.3390/children11040392.


Scar Epilepsy as a Complication of Subarachnoid Hemorrhage in a Patient With Adult Polycystic Kidney Disease: A Case Report.

Khan A, Anwar M, Zaidi F, Ghabsha S, Ur Rehman A Cureus. 2023; 15(7):e41537.

PMID: 37554616 PMC: 10404565. DOI: 10.7759/cureus.41537.

References
1.
Sweeney Jr W, Avner E . Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res. 2006; 326(3):671-85. DOI: 10.1007/s00441-006-0226-0. View

2.
Breslow N, Collins A, Ritchey M, Grigoriev Y, Peterson S, Green D . End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol. 2005; 174(5):1972-5. PMC: 1483840. DOI: 10.1097/01.ju.0000176800.00994.3a. View

3.
Gabow P, Johnson A, Kaehny W, Kimberling W, Lezotte D, Duley I . Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992; 41(5):1311-9. DOI: 10.1038/ki.1992.195. View

4.
Taylor M, Johnson A, Tison M, Fain P, Schrier R . Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications. Am J Kidney Dis. 2005; 46(3):415-23. DOI: 10.1053/j.ajkd.2005.05.029. View

5.
Florijn K, Chang P, van der Woude F, van Bockel J, van Saase J . Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation. Transplantation. 1994; 57(1):73-81. DOI: 10.1097/00007890-199401000-00014. View